For research use only. We do not sell to patients.
| Name | IRAK-1-4 Inhibitor I |
|---|---|
| Iupac Chemical Name | N-(2-Morpholinylethyl)-2-(3-nitrobenzoylamido)-benzimidazole, 1-(2-(4-Morpholinyl)ethyl)-2-(3-nitrobenzoylamino)benzimidazole |
| Synonyms | IRAK-1/4 INHIBITOR |
| Molecular Formula | C20H21N5O4 |
| Molecular Weight | 395.417 |
| Smile | COC(=O)c1csc(n1)C(=O)c2c[nH]c3c2cccc3 |
| InChiKey | KDDXOGDIPZSCTM-UHFFFAOYSA-N |
| InChi | InChI=1S/C14H10N2O3S/c1-19-14(18)11-7-20-13(16-11)12(17)9-6-15-10-5-3-2-4-8(9)10/h2-7,15H,1H3 |
| CAS Number | 448906-42-1 |
| MDL | MFCD06411597 |
| Related CAS |
| Packaging | Price | Availability | Purity | Shipping Time |
|---|---|---|---|---|
| Bulk | Enquiry | Enquiry | Enquiry |
| Formulation | Solid powder |
|---|---|
| Purity | 98% by HPLC |
| Storage | -20 ºC for 3 years |
| Solubility | Soluble in DMSO |
| Handling | |
| Shipping Condition | Shipped under ambient temperature |
| HS Code |
| Targets | |
|---|---|
| Mechanism | |
| Cell study | |
| Animal study | |
| Clinical study |